George Sellers
Stock Analyst at Stephens & Co.
(1.04)
# 3,797
Out of 5,182 analysts
45
Total ratings
25.71%
Success rate
-7.5%
Average return
Main Sectors:
Stocks Rated by George Sellers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ESTA Establishment Labs Holdings | Maintains: Overweight | $85 → $90 | $59.01 | +52.52% | 8 | Feb 25, 2026 | |
| GKOS Glaukos | Maintains: Overweight | $115 → $145 | $115.06 | +26.02% | 5 | Jan 2, 2026 | |
| TFX Teleflex | Maintains: Overweight | $275 → $290 | $115.51 | +151.06% | 9 | Aug 2, 2024 | |
| VCEL Vericel | Maintains: Overweight | $56 → $58 | $33.33 | +74.02% | 2 | Aug 2, 2024 | |
| TMDX TransMedics Group | Maintains: Overweight | $151 → $178 | $107.32 | +65.86% | 2 | Aug 2, 2024 | |
| ANIK Anika Therapeutics | Reiterates: Equal-Weight | $24 | $14.92 | +60.86% | 6 | May 29, 2024 | |
| ENOV Enovis | Initiates: Overweight | $72 | $22.52 | +219.72% | 1 | Feb 13, 2024 | |
| APYX Apyx Medical | Maintains: Overweight | $8 → $5 | $3.75 | +33.33% | 2 | Nov 10, 2023 | |
| TMCI Treace Medical Concepts | Reiterates: Equal-Weight | $25 | $1.34 | +1,765.67% | 4 | Sep 12, 2023 | |
| STAA STAAR Surgical Company | Reiterates: Overweight | $57 | $21.09 | +170.27% | 6 | Aug 14, 2023 |
Establishment Labs Holdings
Feb 25, 2026
Maintains: Overweight
Price Target: $85 → $90
Current: $59.01
Upside: +52.52%
Glaukos
Jan 2, 2026
Maintains: Overweight
Price Target: $115 → $145
Current: $115.06
Upside: +26.02%
Teleflex
Aug 2, 2024
Maintains: Overweight
Price Target: $275 → $290
Current: $115.51
Upside: +151.06%
Vericel
Aug 2, 2024
Maintains: Overweight
Price Target: $56 → $58
Current: $33.33
Upside: +74.02%
TransMedics Group
Aug 2, 2024
Maintains: Overweight
Price Target: $151 → $178
Current: $107.32
Upside: +65.86%
Anika Therapeutics
May 29, 2024
Reiterates: Equal-Weight
Price Target: $24
Current: $14.92
Upside: +60.86%
Enovis
Feb 13, 2024
Initiates: Overweight
Price Target: $72
Current: $22.52
Upside: +219.72%
Apyx Medical
Nov 10, 2023
Maintains: Overweight
Price Target: $8 → $5
Current: $3.75
Upside: +33.33%
Treace Medical Concepts
Sep 12, 2023
Reiterates: Equal-Weight
Price Target: $25
Current: $1.34
Upside: +1,765.67%
STAAR Surgical Company
Aug 14, 2023
Reiterates: Overweight
Price Target: $57
Current: $21.09
Upside: +170.27%